Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $93.90 million. The enterprise value is $59.24 million.

Market Cap	93.90M
Enterprise Value	59.24M

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025, before market open.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Immunic has 95.82 million shares outstanding. The number of shares has increased by 126.03% in one year.

Current Share Class	95.82M
Shares Outstanding	95.82M
Shares Change (YoY)	+126.03%
Shares Change (QoQ)	-0.56%
Owned by Insiders (%)	1.18%
Owned by Institutions (%)	28.18%
Float	68.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.79
P/TBV Ratio	5.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.05.

Current Ratio	1.77
Quick Ratio	1.64
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -424.44% and return on invested capital (ROIC) is -246.62%.

Return on Equity (ROE)	-424.44%
Return on Assets (ROA)	-128.79%
Return on Invested Capital (ROIC)	-246.62%
Return on Capital Employed (ROCE)	-524.54%
Revenue Per Employee	n/a
Profits Per Employee	-$1.10M
Employee Count	91
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.82% in the last 52 weeks. The beta is 1.92, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.92
52-Week Price Change	-23.82%
50-Day Moving Average	1.08
200-Day Moving Average	1.24
Relative Strength Index (RSI)	45.25
Average Volume (20 Days)	661,437

Short Selling Information

The latest short interest is 2.02 million, so 2.11% of the outstanding shares have been sold short.

Short Interest	2.02M
Short Previous Month	2.32M
Short % of Shares Out	2.11%
Short % of Float	2.93%
Short Ratio (days to cover)	3.25

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-98.05M
Pretax Income	-95.31M
Net Income	-100.51M
EBITDA	-97.92M
EBIT	-98.05M
Earnings Per Share (EPS)	-$1.00

Full Income Statement

Balance Sheet

The company has $35.67 million in cash and $1.00 million in debt, giving a net cash position of $34.66 million or $0.36 per share.

Cash & Cash Equivalents	35.67M
Total Debt	1.00M
Net Cash	34.66M
Net Cash Per Share	$0.36
Equity (Book Value)	18.43M
Book Value Per Share	0.20
Working Capital	17.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$84.77 million and capital expenditures -$264,000, giving a free cash flow of -$85.03 million.

Operating Cash Flow	-84.77M
Capital Expenditures	-264,000
Free Cash Flow	-85.03M
FCF Per Share	-$0.89

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-126.03%
Shareholder Yield	n/a
Earnings Yield	-107.03%
FCF Yield	-90.55%

Analyst Forecast

The average price target for Immunic is $13.20, which is 1,253.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.20
Price Target Difference	1,253.71%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1